The course of SARS-CoV-2 infection can vary considerably from person to person. Some experience only mild symptoms, whereas others require hospitalization. New research shows that the presence of autoantibodies against type I interferons can help predict those most at-risk of severe disease.
Biggest Risk Factor For Severe Covid-19 Other Than Age? Autoantibodies
